180 Life Net Worth
180 Life Net Worth Breakdown | ATNF |
180 Life Net Worth Analysis
180 Life's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including 180 Life's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of 180 Life's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform 180 Life's net worth analysis. One common approach is to calculate 180 Life's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares 180 Life's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing 180 Life's net worth. This approach calculates the present value of 180 Life's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of 180 Life's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate 180 Life's net worth. This involves comparing 180 Life's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into 180 Life's net worth relative to its peers.
Enterprise Value |
|
To determine if 180 Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding 180 Life's net worth research are outlined below:
180 Life Sciences is way too risky over 90 days horizon | |
180 Life Sciences appears to be risky and price may revert if volatility continues | |
180 Life Sciences has a very high chance of going through financial distress in the upcoming years | |
180 Life Sciences currently holds 1.05 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. 180 Life Sciences has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about 180 Life's use of debt, we should always consider it together with its cash and equity. | |
Net Loss for the year was (19.94 M) with profit before overhead, payroll, taxes, and interest of 0. | |
180 Life Sciences currently holds about 1.63 M in cash with (10.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04. | |
180 Life Sciences has a poor financial position based on the latest SEC disclosures | |
Latest headline from news.google.com: ARMISTICE CAPITAL, LLC Acquires New Stake in 180 Life Sciences C - GuruFocus.com |
180 Life uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in 180 Life Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to 180 Life's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
29th of March 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
Know 180 Life's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as 180 Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading 180 Life Sciences backward and forwards among themselves. 180 Life's institutional investor refers to the entity that pools money to purchase 180 Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Ubs Group Ag | 2024-09-30 | 6.8 K | Citadel Advisors Llc | 2024-06-30 | 0.0 | Tower Research Capital Llc | 2024-09-30 | 2.3 K | Blackrock Inc | 2024-06-30 | 772 | Bank Of America Corp | 2024-06-30 | 12.0 | Royal Bank Of Canada | 2024-06-30 | 11.0 | Semmax Financial Advisors Inc. | 2024-09-30 | 2.0 | Qube Research & Technologies | 2024-09-30 | 0.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Jpmorgan Chase & Co | 2024-09-30 | 0.0 | Ifp Advisors, Llc | 2024-06-30 | 0.0 |
Follow 180 Life's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.71 M.Market Cap |
|
Project 180 Life's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (5.48) | (5.75) | |
Return On Capital Employed | (68.46) | (65.04) | |
Return On Assets | (3.79) | (3.98) | |
Return On Equity | 156.07 | 163.87 |
When accessing 180 Life's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures 180 Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of 180 Life's profitability and make more informed investment decisions.
Evaluate 180 Life's management efficiency
180 Life Sciences has return on total asset (ROA) of (0.635) % which means that it has lost $0.635 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.9858) %, meaning that it created substantial loss on money invested by shareholders. 180 Life's management efficiency ratios could be used to measure how well 180 Life manages its routine affairs as well as how well it operates its assets and liabilities. The 180 Life's current Return On Equity is estimated to increase to 163.87, while Return On Tangible Assets are projected to decrease to (5.75). At this time, 180 Life's Net Tangible Assets are most likely to increase significantly in the upcoming years. The 180 Life's current Debt To Assets is estimated to increase to 0.21, while Non Current Assets Total are projected to decrease to roughly 1.5 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | (0.34) | (0.32) | |
Tangible Book Value Per Share | (4.61) | (4.38) | |
Enterprise Value Over EBITDA | (0.03) | (0.03) | |
Price Book Value Ratio | (12.05) | (11.44) | |
Enterprise Value Multiple | (0.03) | (0.03) | |
Price Fair Value | (12.05) | (11.44) | |
Enterprise Value | 709.6 K | 674.1 K |
Leadership effectiveness at 180 Life Sciences is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Return On Equity (3.99) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific 180 Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on 180 Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases 180 Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
180 Life Corporate Filings
S1 | 15th of November 2024 Report filed by companies planning on going public to register their securities with the U.S. Securities and Exchange Commission (SEC) | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
12th of November 2024 Other Reports | ViewVerify | |
8K | 31st of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
180 Life Earnings per Share Projection vs Actual
180 Life Corporate Executives
Elected by the shareholders, the 180 Life's board of directors comprises two types of representatives: 180 Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 180. The board's role is to monitor 180 Life's management team and ensure that shareholders' interests are well served. 180 Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, 180 Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
Already Invested in 180 Life Sciences?
The danger of trading 180 Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of 180 Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than 180 Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile 180 Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether 180 Life Sciences is a strong investment it is important to analyze 180 Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact 180 Life's future performance. For an informed investment choice regarding 180 Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 180 Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 180 Life. If investors know 180 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 180 Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 7.98 | Return On Assets (0.64) | Return On Equity (3.99) |
The market value of 180 Life Sciences is measured differently than its book value, which is the value of 180 that is recorded on the company's balance sheet. Investors also form their own opinion of 180 Life's value that differs from its market value or its book value, called intrinsic value, which is 180 Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 180 Life's market value can be influenced by many factors that don't directly affect 180 Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 180 Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if 180 Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 180 Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.